Challenges in implementing 2021 WHO CNS tumor classification in a resource-limited setting
Without access to molecular testing, up to a third of all glial, embryonal, and glioneuronal tumors could not be assigned a CNS5 diagnosis, leading to diagnostic ambiguity and therapeutic confusion. Until affordable molecular assays are available, CNS5 diagnostic criteria have limited applicability in resource-limited settings.
Authors
- Khurram Minhas (ORCID: https://orcid.org/0000-0002-6210-4636)
- Ahmed Gilani (ORCID: https://orcid.org/0000-0003-2215-2892)
- Syed Ather Enam (ORCID: https://orcid.org/0000-0003-2194-0723)
- Altaf Ahmed (ORCID: https://orcid.org/0000-0002-6473-771X)
- Muhammad Shakir (ORCID: https://orcid.org/0000-0002-7233-1584)
Institutions
- Aga Khan University (PK)
- Aga Khan University Hospital Nairobi (KE)
- Aga Khan University Hospital (PK)
- Aga Khan University (TZ)
- University of Colorado Anschutz Medical Campus (US)
Publication Details
- Journal
- Neuro-Oncology Practice
- Published
- 2024-12-22
- DOI
- https://doi.org/10.1093/nop/npae124
- Citations
- 1
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.44